Nair DR, Monteiro JM, Memmi G, Thanassi J, Pucci M, Schwartzman J, Pinho MG, Cheung AL.
Characterization of a novel small molecule that potentiates β-lactam activity against gram-positive and gram-negative pathogens [Internet]. Antimicrob Agents Chemother 2015;59(4):1876–1885.
Publisher's Version Alekseyenko AA, Walsh EM, Wang X, Grayson AR, Hsi PT, Kharchenko PV, Kuroda MI, French CA.
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains [Internet]. Genes Dev 2015;29(14):1507–1523.
Publisher's Version CRISPR and TALEN support - GEPG. Genome Engineering Production Group (GEPG) is an on-campus (HMS) resource for custom CRISPR sgRNA and TALE nuclease expression constructs. 2015;
Medicinal Chemistry Core. The Medicinal Chemistry Core at DFCI collaborates with investigators on the development of small molecule probes and lead therapeutics. 2015;
Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You MH, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke NJ, Cao S, Reschke M, Chen CH, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Zhang Y, Pandolfi PP, Zhou XZ, Lu KP.
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nat Med 2015;21(5):457-66.
Radomska HS, Jernigan F, Nakayama S, Jorge SE, Sun L, Tenen DG, Kobayashi SS.
A Cell-Based High-Throughput Screening for Inducers or Myeloid Differentiation. J Biomol Screen 2015;20(9):1150-9.
Landeta C, Blazyk JL, Hatahet F, Meehan BM, Eser M, Myrick A, Bronstain L, Minami S, Arnold H, Ke N, Rubin EJ, Furie BC, Furie B, Beckwith J, Dutton R, Boyd D.
Compounds targeting disulfide bond forming enzyme DsbB of Gram-negative bacteria. Nat Chem Biol 2015;11(4):292-8.
Wallace J, Bowlin NO, Mills DM, Saenkham P, Kwasny SM, Opperman T, Williams DJ, Rock CO, Bowlin TL, Moir DT.
Discovery of Bacterial Fatty Acid Synthase Type II Inhibitors Using a Novel Cellular Bioluminescent Reporter Assay. Antimicrob Agents Chemother 2015;59(9):5775-87.
Yi T, Arthanari H, Akabayov B, Song H, Papadopoulos E, Qi HH, Jedrychowski M, Guttler T, Guo C, Luna RE, Gygi SP, Huang SA, Wagner G.
elF1A augments Ago2-mediated Dicer-independent miRNA biogenesis and RNA interference. Nat Commun. 2015;6:7194.
Medvetz D, Sun Y, Li C, Khabibulin D, Balan M, Parkhitko A, Priolo C, Asara JM, Pal S, Yu J, Henske EP.
High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null setting. Mol Cancer Res 2015;13(1):50-62.
Park CY, Zhou EH, Tambe D, Chen B, Lavoie T, Dowell M, Simeonov A, Maloney DJ, Marinkovic A, Tschumperlin DJ, Burger S, Frykenberg M, Butler JP, Stamer WD, Johnson M, Solway J, Fredberg JJ, Krishnan R.
High-throughput screening for modulators of cellular contractile force. Integr Biol (Camb). 2015;7(10):1318-24.
Pery E, Sheehy A, Nebane NM, Brazier AJ, Misra V, Rajendran KS, Buhrlage SJ, Mankowski M, Rasmussen L, White EL, Ptak RG, Gabuzda D.
Identification of novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein. J Biol Chem 2015;290(16):10504-17.
Pery E, Sheehy A, Nebane MN, Misra V, Mankowski M, Rasmussen L, White LE, Ptak RG, Gabuzda D.
Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1. Virology. 2015;484:276-87.
Crowther GJ, Weller SM, Jones JC, Weaver T, Fan E, Voorhis WCV, Rosen H.
The Bacterial Sec Pathway of Protein Export: Screening and Follow-Up. J Biomol Screen 2015;20(7):921-6.
Carocci M, Hinshaw SM, Rodgers MA, Villareal VA, Burri DJ, Pilankatta R, Maharaj NP, Gack MU, Stavale EJ, Warfield KL, Yang PL.
The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication. Antimicrob Agents Chemother 2015;59(1):85-95.